Design and Development of New Antimicrobial Agents

 Group Leader: Prof. PharmDr. Martin Doležal, Ph.D.


  • Synthesis and biological evaluation of new antibacterial derivatives, mainly those based on pyrazine and similar heterocycles
  • Evaluation of antimycobacterial activity against M. tuberculosis H37Rv and non-tuberculous mycobacteria (M. avium, M. kansasii, M. smegmatis, M. aurum)
  • Evaluation of antibacterial activity against selected G+ and G- bacterial pathogens, including drug-resistant strains
  • Evaluation of antifungal activity against selected fungi and yeasts
  • Determination of photosynthesis inhibitory activity of pyrazine derivatives (with potential use as herbicides)
  • Pyrazine derivatives as abiotic elicitors (i.e. compounds capable of promoting synthesis of selected secondary metabolites in plants)
  • Pyrazine-2-carboxamide derivatives as inhibitors of aminoacyl-tRNA synthetases
  • In silico simulations of druglike molecules and their interactions to targets - docking, MD, QM
ccg_logo-(1).gif moe_slogan-(1).png

Using MOE (Molecular Operating Environment) software package developed by Chemical Computing Group, Montreal, QC, Canada.

© Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 03 Hradec Králové, Czech Republic
Website information | Powered by Kentico